These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17541252)

  • 1. Quantification of cibenzoline by enzyme-linked immunosorbent assay.
    Saita T; Tokunaga A; Egoshi M; Tokushima H; Fujito H
    Yakugaku Zasshi; 2007 Jun; 127(6):1007-12. PubMed ID: 17541252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of a specific and sensitive enzyme-linked immunosorbent assay for vindesine].
    Nakano Y; Saita T; Fujito H
    Yakugaku Zasshi; 2012; 132(6):727-32. PubMed ID: 22687732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of enzyme-linked immunosorbent assay for therapeutic drug monitoring of mexiletine.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2003 Jun; 26(6):761-5. PubMed ID: 12808282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELISA for the quantification of pilsicainide.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2001 Oct; 24(10):1113-6. PubMed ID: 11642313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly sensitive ELISA for the quantification of polymyxin B sulfate in human serum.
    Saita T; Yoshida M; Nakashima M; Matsunaga H; Fujito H; Mori M
    Biol Pharm Bull; 1999 Dec; 22(12):1257-61. PubMed ID: 10746150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly sensitive enzyme-linked immunosorbent assay for etoposide using beta-D-galactosidase as a label.
    Saita T; Fujiwara K; Kitagawa T; Mori M; Takata K
    Cancer Chemother Pharmacol; 1990; 27(2):115-20. PubMed ID: 2123420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific and sensitive assay for gefitinib using the enzyme-linked immunosorbent assay in human serum.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2005 Oct; 28(10):1833-7. PubMed ID: 16204931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an enzyme-linked immunosorbent assay for measurement of sotalol.
    Saita T; Fujito H; Nakano Y; Mori M
    Biol Pharm Bull; 2004 Jan; 27(1):94-6. PubMed ID: 14709906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of a Sensitive Enzyme-linked Immunosorbent Assay for Daptomycin].
    Yamamoto Y; Saita T; Oka A; Kataoka H; Yamamoto Y; Shin M
    Yakugaku Zasshi; 2021; 141(3):427-431. PubMed ID: 33642512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure elevates serum levels of cibenzoline in arrhythmic patients.
    Kotake T; Takada M; Komamura K; Kamakura S; Miyatake K; Kitakaze M; Morishita H
    Circ J; 2006 May; 70(5):588-92. PubMed ID: 16636495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a specific and sensitive enzyme-linked immunosorbent assay for the quantification of imatinib.
    Saita T; Shin M; Fujito H
    Biol Pharm Bull; 2013; 36(12):1964-8. PubMed ID: 24292055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an enzyme-linked immunosorbent assay for the quantification of amiodarone.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2002 Aug; 25(8):954-8. PubMed ID: 12186425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay for the quantification of actinomycin D using beta-D-galactosidase as a label.
    Fujiwara K; Saita T; Takenawa N; Matsumoto N; Kitagawa T
    Cancer Res; 1988 Sep; 48(17):4843-7. PubMed ID: 3136914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
    Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
    J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay (ELISA) for luteinizing hormone releasing hormone (LH-RH) using a heterobifunctional cross-linking agent, N-[beta-(4-diazophenyl)ethyl]maleimide.
    Fujiwara K; Saita T; Kitagawa T
    Biol Pharm Bull; 1993 Nov; 16(11):1073-7. PubMed ID: 8312857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral cibenzoline in arrhythmia patients.
    Brazzell RK; Colburn WA; Aogaichi K; Szuna AJ; Somberg JC; Carliner N; Heger J; Morganroth J; Winkle RA; Block P
    Clin Pharmacokinet; 1985; 10(2):178-86. PubMed ID: 3995859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of furanocoumarin derivatives in citrus fruits by enzyme-linked immunosorbent assay.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2004 Jul; 27(7):974-7. PubMed ID: 15256725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of Sorafenib in Human Serum by Competitive Enzyme-Linked Immunosorbent Assay.
    Saita T; Yamamoto Y; Noda S; Shioya M; Hira D; Andoh A; Morita SY; Terada T; Shin M
    Biol Pharm Bull; 2015; 38(11):1788-93. PubMed ID: 26521829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.